Zobrazeno 1 - 10 of 36 pro vyhledávání: '"Keri M. Shafer"'
2
Activity During the COVID-19 Pandemic in Children with Cardiac Rhythm Management Devices
Autor: Naomi S. Gauthier, Matthew Lippmann, Molly Craig, Douglas Y. Mah, Keri M. Shafer, Sarah D. de Ferranti, Robert Przybylski, John K. Triedman, Mark E. Alexander
Publikováno v: Pediatric Cardiology
Decreased physical activity is associated with cardiovascular, metabolic and mental health disease. While decreases in physical activity during the COVID-19 pandemic have been described in the general population, there is a paucity of data regarding
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efc4ae132c6cc7fa8faefe4e1e9788d8
https://doi.org/10.1007/s00246-021-02787-8
Zobrazit plný text záznamu
3
Abstract 12213: Exercise Induced Pulmonary Hypertension in Long Term Survivors of Congenital Diaphragmatic Hernia
Autor: Paul J Critser, Ming Hui Chen, Kimberlee Gauvreau, Jill M Zalieckas, Catherine A Sheils, Gary A Visner, Keri M Shafer, Jonathan Rhodes, Terry L Buchmiller, Mary P Mullen
Publikováno v: Circulation. 144
Introduction: Survivors of congenital diaphragmatic hernia (CDH) are at risk of pulmonary hypertension (PH) due to pulmonary hypoplasia and other pulmonary vascular abnormalities. Hypothesis: Exercise stress echocardiography (ESE) may detect PH, not
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5cb8541b3c964306a28867b7de2ace7f
https://doi.org/10.1161/circ.144.suppl_1.12213
Zobrazit plný text záznamu
4
Reducing radiation dose from myocardial perfusion imaging in subjects with complex congenital heart disease
Autor: Hicham Skali, Anne Marie Valente, Marcelo F. DiCarli, Viviany R. Taqueti, Neha Kwatra, Sara L. Partington, Sharmila Dorbala, Michael J. Landzberg, Dillenia Rosica, Keri M. Shafer, John Bruyere, Ron Blankstein, Frederick D. Grant
Publikováno v: J Nucl Cardiol
INTRODUCTION. The prevalence of defects and effective radiation dose from various myocardial perfusion imaging (MPI) strategies in congenital heart disease (CHD) is unknown. METHODS. We studied 75 subjects with complex CHD (ages 5 to 80 years) referr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e77a410b06a198aa0bf26c5054824444
https://doi.org/10.1007/s12350-019-01811-y
Zobrazit plný text záznamu
6
Abstract 12598: Stress Testing During Long-term Follow-up After Kawasaki Disease
Autor: Annette L. Baker, Audrey Dionne, Andrew J. Powell, Sarah D. de Ferranti, Meaghan J Beattie, Kevin G. Friedman, Jane W. Newburger, Keri M. Shafer, David Fulton, Ming-Hui Chen, Thomas Giorgio
Publikováno v: Circulation. 142
Introduction: The American Heart Association (AHA) guidelines recommend testing for inducible myocardial ischemia in all patients with a history of coronary artery aneurysm (CAA) after Kawasaki disease (KD). Because the prevalence of clinical coronar
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ca074c772e755d1f9adcedeecca70bc5
https://doi.org/10.1161/circ.142.suppl_3.12598
Zobrazit plný text záznamu
7
Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study
Autor: Gertjan T. Sieswerda, Gruschen R. Veldtman, Barbara J.M. Mulder, Rafael Alonso-Gonzalez, Daniel Tobler, Magdalena Lipczyńska, Lina Gumbiene, Tobias Rutz, Martijn C. Post, Giancarlo Scognamiglio, Magalie Ladouceur, B.J. Bouma, Konstantinos Dimopoulos, Folkert J. Meijboom, Werner Budts, Matthias Greutmann, Jonathan Buber, Jamil Aboulhosn, H. Yang, Marielle Morissens, M. Laukyte, Gary Webb, S. F. Tsai, T.C. Konings, Alexander C. Egbe, Tabitha G. Moe, Judith Bouchardy, Craig S. Broberg, W. Davidson, Paul Khairy, Koichiro Niwa, Kristofer Skoglund, C. Christersson, Keri M. Shafer, Alexander R. Opotowsky, Atsushi Mizuno, Markus Schwerzmann, A.P.J. van Dijk, T. Kronvall, S. Chakrabarti
Publikováno v: International journal of cardiology, Shannon : Elsevier Ireland Ltd, 2020, vol. 299, p. 123-130
International journal of cardiology
Yang, H; Bouma, B J; Dimopoulos, K; Khairy, P; Ladouceur, M; Niwa, K; Greutmann, M; Schwerzmann, Markus; Egbe, A; Scognamiglio, G; Budts, W; Veldtman, G; Opotowsky, A R; Broberg, C S; Gumbiene, L; Meijboom, F J; Rutz, T; Post, M C; Moe, T; Lipczyńska, M; ... (2020). Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study. International journal of cardiology, 299, pp. 123-130. Elsevier 10.1016/j.ijcard.2019.06.014
International Journal of Cardiology, 299, pp. 123-130
International journal of cardiology, 299, 123-130. Elsevier Ireland Ltd
International Journal of Cardiology, 299, 123-130. Elsevier Ireland Ltd
Yang, H, Bouma, B J, Dimopoulos, K, Khairy, P, Ladouceur, M, Niwa, K, Greutmann, M, Schwerzmann, M, Egbe, A, Scognamiglio, G, Budts, W, Veldtman, G, Opotowsky, A R, Broberg, C S, Gumbiene, L, Meijboom, F J, Rutz, T, Post, M C, Moe, T, Lipczyńska, M, Tsai, S F, Chakrabarti, S, Tobler, D, Davidson, W, Morissens, M, van Dijk, A, Buber, J, Bouchardy, J, Skoglund, K, Christersson, C, Kronvall, T, Konings, T C, Alonso-Gonzalez, R, Mizuno, A, Webb, G, Laukyte, M, Sieswerda, G T J, Shafer, K, Aboulhosn, J & Mulder, B J M 2020, ' Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study ', International Journal of Cardiology, vol. 299, pp. 123-130 . https://doi.org/10.1016/j.ijcard.2019.06.014
International Journal of Cardiology, 299, 123-130
International Journal of Cardiology, 299, 123. Elsevier Ireland Ltd
Background: Current guidelines consider vitamin K antagonists (VKA) the oral anticoagulant agents of choice in adults with atrial arrhythmias (AA) and moderate or complex forms of congenital heart disease, significant valvular lesions, or bioprosthet
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04038706be5346bf94421f3f82dedf0d
https://repository.vu.lt/VU:ELABAPDB44795311&prefLang=en_US
Zobrazit plný text záznamu
8
Contrast volume to estimated glomerular filtration rate ratio for prediction of contrast‐induced acute kidney injury after cardiac catheterization in adults with congenital heart disease
Autor: Lisa Bergersen, Kimberlee Gauvreau, Diego Porras, Laura Gellis, Michael A. J. Ferguson, Keri M. Shafer
Publikováno v: Catheterization and Cardiovascular Interventions. 92:1301-1308
BACKGROUND Adults with congenital heart disease (ACHD) are vulnerable to contrast-induced acute kidney injury (CI-AKI) after cardiac catheterization. The aim of this study was to identify risk factors for clinically significant CI-AKI and evaluate th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::895cd896925848cccad23a627fc24ca1
https://doi.org/10.1002/ccd.27798
Zobrazit plný text záznamu
9
A Randomized Trial Comparing Cardiac Rehabilitation to Standard of Care for Adults With Congenital Heart Disease
Autor: Alexander R. Opotowsky, Scott E. Crouter, Jonathan Rhodes, Ana Ubeda Tikkanen, Ami B. Bhatt, Keri M. Shafer, Doreen DeFaria Yeh, Michael J. Landzberg
Publikováno v: World Journal for Pediatric and Congenital Heart Surgery. 9:185-193
Background: Cardiac rehabilitation (CR) improves exercise capacity and quality of life while reducing mortality in adults with acquired heart disease. Cardiac rehabilitation has not been extensively studied in adults with congenital heart disease (CH
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b44dd350adb22ce1e132bc9c697dcff2
https://doi.org/10.1177/2150135117752123
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje